Literature DB >> 8230198

Nuclear magnetic resonance structural studies of A.AT base triple alignments in intramolecular purine.purine.pyrimidine DNA triplexes in solution.

I Radhakrishnan1, C de los Santos, D J Patel.   

Abstract

This study reports on an NMR characterization of an intramolecular purine.purine.pyrimidine (R.RY) triplex containing a central A.AT triple in addition to G.GC and T.AT triples. Our studies establish an A(anti).AT alignment with reversed Hoogsteen pairing stabilized by two N6H ... N hydrogen bonds between adenine residues in the third strand and the purine strand of the duplex. This result, combined with our earlier demonstration of G(anti).GC and T(anti).AT pairing alignments, has provided a definitive experimental approach for differentiating between the base triple pairing possibilities proposed previously by Beal and Dervan for R.RY triplexes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230198     DOI: 10.1006/jmbi.1993.1573

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

1.  Stabilisation of TG- and AG-containing antiparallel DNA triplexes by triplex-binding ligands.

Authors:  M D Keppler; S Neidle; K R Fox
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Parallel and antiparallel A*A-T intramolecular triple helices.

Authors:  C Dagneaux; H Gousset; A K Shchyolkina; M Ouali; R Letellier; J Liquier; V L Florentiev; E Taillandier
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides.

Authors:  M Musso; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

4.  Comparison of antiparallel A.AT and T.AT triplets within an alternate strand DNA triple helix.

Authors:  E Washbrook; K R Fox
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.